Trials / Conditions / Treatment-Refractory Solid Tumors
Treatment-Refractory Solid Tumors
3 registered clinical trials studyying Treatment-Refractory Solid Tumors — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients NCT07170592 | Bionoxx Inc. | Phase 1 |
| Recruiting | A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients NCT07190833 | Bionoxx Inc. | Phase 1 |
| Withdrawn | TAS-116 Plus Palbociclib in Breast and Rb-null Cancer NCT05655598 | Brown University | Phase 1 |